ID2 and breast carcinoma: Others have also observed an inverse correlation in ID1 and ID2 expression in patients’ chronic myelogenous leukemia (CML) and blast crisis cells and in nonhematopoietic tissue, where loss of ID2 expression and overexpression of ID1 promote colon and breast cancer (11, 74–76).